PACIRA BIOSCIENCES, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $4.7M | $2.9M | $1.6M | $5.4M | $-4.8M | $4.8M | $16.0M | $-143.5M |
| Depreciation & Amortization | $21.3M | $21.3M | $21.3M | $21.2M | $27.3M | $21.2M | $21.2M | $20.3M |
| Depreciation | $7.0M | $7.0M | $7.0M | $6.9M | $13.0M | $6.8M | $6.9M | $6.0M |
| Amortization | $14.3M | $14.3M | $14.3M | $14.3M | $14.3M | $14.3M | $14.3M | $14.3M |
| Stock-Based Compensation | $15.0M | $13.5M | $13.5M | $14.0M | $15.5M | $14.6M | $12.3M | $13.2M |
| Net Cash from Operating Activities | $57.5M | $25.7M | $43.7M | $60.8M | $12.0M | $35.5M | $33.1M | $53.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $1.3M | $2.7M | $218.0K | $3.9M | $2.7M | $8.5M | $2.1M | $4.1M |
| Business Acquisitions | $0 | $335.0K | $0 | $0 | $0 | $16.7M | $0 | $0 |
| Net Cash from Investing Activities | $11.8M | $19.4M | $19.3M | $43.6M | $62.2M | $-25.6M | $-368.0K | $-52.2M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $0 | $50.0M | $48.2M | $50.0M | $50.0M | $0 | — | — |
| Net Cash from Financing Activities | $-7.7M | $-59.4M | $-51.7M | $-257.5M | $-57.5M | $-3.0M | $-2.0M | $-2.8M |
| Net Change in Cash | $61.6M | $-14.2M | $11.0M | $-152.9M | $16.9M | $6.8M | $30.8M | $-1.1M |
| Free Cash Flow | $56.1M | $23.0M | $43.5M | $57.0M | $9.3M | $26.9M | $31.0M | $49.8M |